BiondVax Pharmaceuticals Ltd (BVXV): BiondVax CEO to Present Universal Flu Va...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27566
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Thursday, 06/02/2016 8:52:50 AM

Thursday, June 02, 2016 8:52:50 AM

BiondVax CEO to Present Universal Flu Vaccine Technology at BIO International Convention

NESS ZIONA, Israel, June 2, 2016 /PRNewswire/ --

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) announced today that BiondVax's CEO, Dr. Ron Babecoff, will be presenting and participating in a panel discussion at BIO International Convention in San Francisco.

The session, titled "Solving the Flu Problem: Can New Technologies Lead to Universal Flu Vaccines?" will be held on Tuesday, June 7 at 1:00pm in the Moscone Center, room West 3004.

Dr. Babecoff will discuss the technology and promising clinical trial results of M-001, BiondVax's universal flu vaccine candidate. Also participating in the panel moderated by the US Biomedical Advanced Research and Development Authority (BARDA) will be representatives from FluGen and Janssen Pharmaceuticals.

Accompanying Dr. Babecoff will be Dr. Tamar Ben-Yedidia, BiondVax's Chief Science Officer. Those wishing to meet with Drs. Babecoff and Ben-Yedidia are invited to contact BiondVax's Business Development team.